Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$229/ year*
Daily Morning INK newsletter
+1 year archive
Canadian Market INK weekly newsletter
+1 year archive
3 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you cancel with-in 30 days of first subscribing, we will refund your payment upon request. After cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Marketwired News Releases

Apr 04, 2018 10:04 ET
ORYZON receives approval to start ETHERAL: a Phase IIa clinical trial in Alzheimer's Disease with ORY-2001
Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that it has received approval of a...
Apr 04, 2018 08:30 ET
Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System...
Apr 04, 2018 08:00 ET
Florida Company Orders Three Tecochill RT-50 Chillers for New HQ
Tecogen Inc. (NASDAQ: TGEN) a leading manufacturer of clean energy cogeneration products that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint, is pleased to announce that a...
Apr 04, 2018 07:30 ET
MagneGas Completes Acquisition of Trico Welding Supply
MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a leading clean technology company in the renewable resources and environmental solutions industries, announced today the completion of the previously announced acquisition of Trico...
Apr 04, 2018 07:26 ET
Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the initiation of screening and enrolment activities in the Phase 3 study of its PPP001 smokable cannabis pellet for advanced cancer patients with uncontrolled pain.
Apr 04, 2018 07:26 ET
Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced the initiation of screening and enrolment activities in the Phase 3 study of its PPP001 smokable cannabis pellet for advanced cancer patients with...
Apr 04, 2018 07:02 ET
Water Technologies International, Inc. Announces Patent Allowance for Mexico adding to the Company's Atmospheric Water Generation Intellectual Property Portfolio
Water Technologies International, Inc. (OTC PINK: WTII) (News) the leader in the technology in atmospheric water generator's production and design announced today that it has been issued a Patent(s) for its Atmospheric Water Generators for the...
Apr 03, 2018 13:55 ET
Tetra Bio-Pharma Names Guy Chamberland as Interim CEO
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced the appointment of Guy Chamberland, M.Sc., Ph.D., an accomplished drug developer, as interim Chief Executive Officer (CEO). This appointment...
Apr 03, 2018 13:55 ET
Tetra Bio-Pharma Names Guy Chamberland as Interim CEO
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the appointment of Guy Chamberland, M.Sc., Ph.D., an accomplished drug developer, as interim Chief Executive Officer (CEO). This appointment is effective immediately.
Apr 03, 2018 09:00 ET
Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018.
Apr 03, 2018 08:58 ET
Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018. The reported record high of 16,549 units,...
Apr 03, 2018 08:50 ET
Envision Solar Announces Record Q1 Revenues Over $3 Million - Exceeding Previous Annual Best
Envision Solar International, Inc., (OTCQB: EVSI) ("Envision Solar," or the "Company"), the leading renewably energized EV charging, outdoor media and energy security products company, today announced unaudited revenue results for the first quarter...
Apr 03, 2018 08:00 ET
CLS Holdings USA, Inc. Acquisition Target Oasis Cannabis Records Highest Wholesale Sales Month in March
CLS Holdings USA, Inc. (OTCQB: CLSH) "CLS," a development stage diversified cannabis company operating as Cannabis Life Sciences, today announced that City Trees, the wholesale division of its acquisition target Oasis Cannabis, recorded its largest...
Apr 03, 2018 07:30 ET
Milestone Scientific Reports 46.9% Increase in Sales for the Fourth Quarter of 2017
Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the...
Apr 02, 2018 17:20 ET
Immune Pharmaceuticals Announces 2017 Financial Results
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ("Immune" or the "Company"), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced financial results for the year and...
Apr 02, 2018 17:00 ET
NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services,announced today that it plans to release its first quarter 2018 financial results on Tuesday, May 1, 2018.The Company has scheduled a web-cast and...
Apr 02, 2018 16:30 ET
Network-1 Reports 2017 Year-End Financial Results
Network-1 Technologies, Inc. (NYSE American: NTIP) (NYSE MKT: NTIP), a company specializing in the development, licensing, and protection of its intellectual property assets, today announced financial results for the year ended December 31, 2017....
Apr 02, 2018 16:05 ET
MagneGas Provides Business Update for Fiscal 2017; Metal Cutting Fuel and Welding Supply Revenues Increased 36%
MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a leading clean technology company in the renewable resources and environmental solutions industries, today announced financial results and provided a business update for the year...
Apr 02, 2018 13:26 ET
Orbital Tracking Corp. Announces Fourth Quarter and Full-Year 2017 Results
Orbital Tracking Corp. (OTCQB: TRKK) ("Orbital Tracking" or the "Company") today reported financial results for its fourth quarter and fiscal year ended December 31, 2017.2017 Company HighlightsDespite further currency weakness affecting EU sales,...
Apr 02, 2018 11:49 ET
Milestone Scientific Schedules 2017 Year-End Earnings Conference Call
Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 4:30 PM Eastern Time...